找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag; Akihiro Hirakawa,Hiroyuki Sato,Shige

[復(fù)制鏈接]
查看: 24713|回復(fù): 35
樓主
發(fā)表于 2025-3-21 19:15:37 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag
編輯Akihiro Hirakawa,Hiroyuki Sato,Shigeyuki Matsui
視頻videohttp://file.papertrans.cn/638/637104/637104.mp4
概述Focuses on the two advanced areas of adaptive model-based dose-finding methods for phase I trials with multiple drugs/outcomes in oncology and other fields.Provides software implementations to facilit
叢書(shū)名稱(chēng)SpringerBriefs in Statistics
圖書(shū)封面Titlebook: Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag;  Akihiro Hirakawa,Hiroyuki Sato,Shige
描述This book deals with advanced methods for adaptive phase I dose-finding clinical trials for combination of two agents and molecularly targeted agents (MTAs) in oncology. It provides not only methodological aspects of the dose-finding methods, but also software implementations and practical considerations in applying these complex methods to real cancer clinical trials. Thus, the book aims to furnish researchers in biostatistics and statistical science with a good summary of recent developments of adaptive dose-finding methods as well as providing practitioners in biostatistics and clinical investigators with advanced materials for designing, conducting, monitoring, and analyzing adaptive dose-finding trials. The topics in the book are mainly related to cancer clinical trials, but many of those topics are potentially applicable or can be extended to trials for other diseases.?The focus is mainly on model-based dose-finding methods for two kinds of phase I trials. One is clinical trials with combinations of two agents. Development of dose-finding methods for two-agent combination trials requires reasonable models that can adequately capture joint toxicity probabilities for two agents
出版日期Book 2018
關(guān)鍵詞Adaptive Design; Cancer; Dose Finding; Phase I; Phase I/II
版次1
doihttps://doi.org/10.1007/978-4-431-55573-5
isbn_softcover978-4-431-55572-8
isbn_ebook978-4-431-55573-5Series ISSN 2191-544X Series E-ISSN 2191-5458
issn_series 2191-544X
copyrightThe Author(s) 2018
The information of publication is updating

書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag影響因子(影響力)




書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag被引頻次




書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag被引頻次學(xué)科排名




書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag年度引用




書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag年度引用學(xué)科排名




書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag讀者反饋




書(shū)目名稱(chēng)Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Ag讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

1票 100.00%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:13:51 | 只看該作者
Book 2018(MTAs) in oncology. It provides not only methodological aspects of the dose-finding methods, but also software implementations and practical considerations in applying these complex methods to real cancer clinical trials. Thus, the book aims to furnish researchers in biostatistics and statistical sc
板凳
發(fā)表于 2025-3-22 01:48:00 | 只看該作者
SpringerBriefs in Statisticshttp://image.papertrans.cn/m/image/637104.jpg
地板
發(fā)表于 2025-3-22 05:55:21 | 只看該作者
https://doi.org/10.1007/978-4-431-55573-5Adaptive Design; Cancer; Dose Finding; Phase I; Phase I/II
5#
發(fā)表于 2025-3-22 12:08:24 | 只看該作者
6#
發(fā)表于 2025-3-22 14:48:41 | 只看該作者
Akihiro Hirakawa,Hiroyuki Sato,Shigeyuki MatsuiFocuses on the two advanced areas of adaptive model-based dose-finding methods for phase I trials with multiple drugs/outcomes in oncology and other fields.Provides software implementations to facilit
7#
發(fā)表于 2025-3-22 18:39:19 | 只看該作者
8#
發(fā)表于 2025-3-23 00:53:05 | 只看該作者
9#
發(fā)表于 2025-3-23 04:15:21 | 只看該作者
10#
發(fā)表于 2025-3-23 07:24:33 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 01:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
博野县| 舞钢市| 乌鲁木齐县| 开原市| 江川县| 乳源| 永和县| 武清区| 榆林市| 个旧市| 日土县| 鲁甸县| 边坝县| 贵溪市| 江油市| 乐清市| 桑日县| 温宿县| 嘉定区| 都昌县| 瑞昌市| 抚远县| 虞城县| 耿马| 哈尔滨市| 新平| 朔州市| 永丰县| 永清县| 济南市| 西青区| 改则县| 沁源县| 宿松县| 龙山县| 合川市| 宁城县| 金华市| 昂仁县| 九龙坡区| 江安县|